MPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
City Health Directorate, Harare, Zimbabwe.
BMC Infect Dis. 2018 Sep 18;18(1):469. doi: 10.1186/s12879-018-3372-6.
BACKGROUND: Zimbabwe is on track towards achieving viral suppression among adults (87%). However, adolescents have only achieved 44% by 2016. In Harare city, 57% of adolescents had attained viral suppression after 12 months on ART compared to 88% among adults. We determined factors associated with virological failure among adolescents (age 10-19 years) on antiretroviral therapy (ART) in Harare city. METHODS: We conducted a one to one unmatched case control study among 102 randomly recruited case: control pairs at the two main infectious disease hospitals in Harare. A case was any adolescent who presented with VL > 1000c/ml after at least 12 months on ART. A control was any adolescent who presented with VL < 1000c/ml after at least 12 months on ART. Interviewer administered questionnaires were used to collect data. Epi Info 7 was used to generate frequencies, means, proportions, ORs and p-values at 95% CI. RESULTS: We interviewed 102 case-control pairs. Poor adherence to ART [aOR = 8.15, 95% CI (2.80-11.70)], taking alcohol [aOR = 8.46, 95% CI (3.22-22.22)] and non- disclosure of HIV status [aOR = 4.56, 95% CI (2.20-9.46)] were independent risk factors for virological failure. Always using a condom [aOR = 0.04, 95% CI (0.01-0.35)], being on second line treatment [aOR = 0.04, 95% CI (0.23-0.81)] and belonging to a support group [aOR = 0.41, 95% CI (0.21-0.80)] were protective. CONCLUSION: Poor adherence, alcohol consumption and non-disclosure increased the odds of virological failure. Based on these findings support should focus on behavior change and strengthening of peer to peer projects to help address issues related to disclosure and adherence. Further operational research should aim to define other components of effective adherence support for adolescents with virological failure.
背景:津巴布韦在实现成年人(87%)病毒抑制方面进展顺利。然而,到 2016 年,青少年的这一比例仅达到 44%。在哈拉雷市,接受抗逆转录病毒治疗(ART)12 个月后,57%的青少年实现了病毒抑制,而成年人这一比例为 88%。我们确定了在哈拉雷市接受抗逆转录病毒治疗(ART)的青少年(10-19 岁)病毒学失败的相关因素。 方法:我们在哈拉雷市的两家主要传染病医院对 102 名随机招募的病例-对照进行了一对一的非匹配病例对照研究。病例为至少接受 12 个月 ART 治疗后病毒载量(VL)>1000c/ml 的青少年。对照为至少接受 12 个月 ART 治疗后 VL<1000c/ml 的青少年。采用访谈者管理的问卷收集数据。使用 Epi Info 7 生成频率、平均值、比例、OR 和 95%CI 的 p 值。 结果:我们共访谈了 102 对病例对照。ART 治疗依从性差(aOR=8.15,95%CI(2.80-11.70))、饮酒(aOR=8.46,95%CI(3.22-22.22))和 HIV 状态未披露(aOR=4.56,95%CI(2.20-9.46))是病毒学失败的独立危险因素。始终使用避孕套(aOR=0.04,95%CI(0.01-0.35))、接受二线治疗(aOR=0.04,95%CI(0.23-0.81))和参加支持小组(aOR=0.41,95%CI(0.21-0.80))是保护性因素。 结论:依从性差、饮酒和未披露会增加病毒学失败的几率。基于这些发现,支持应重点关注行为改变和加强同伴对同伴项目,以帮助解决与披露和依从性相关的问题。进一步的运营研究应旨在确定针对病毒学失败的青少年有效的依从性支持的其他组成部分。
BMC Infect Dis. 2018-9-18
J Acquir Immune Defic Syndr. 2017-9-1
Int J MCH AIDS. 2025-5-9
J Acquir Immune Defic Syndr. 2014-9-1
AIDS Patient Care STDS. 2014-3
AIDS Res Hum Retroviruses. 2013-6
J Nurs Scholarsh. 2009
Curr Opin HIV AIDS. 2009-7
J Acquir Immune Defic Syndr. 2009-5-1